Moxonidine treatment was associated with lower recurrence risk after adjustment for age , body mass index , number of AF episodes in the previous year , and left atrial diameter ( adjusted hazard ratio , @ -LSB- @ % CI , @-@ @ -RSB- ; P < @ ) .